![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 39/395 | |
A61K 31/404 | |||
C07K 14/47 | |||
C12N 9/48 | |||
C12N 9/64 | |||
A61K 9/00 | |||
A61K 31/7088 | |||
C07K 16/28 | |||
C07K 16/30 | |||
A61K 39/00 |
(11) | Patento numeris | 2844282 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 13729083.9 |
Europos patento paraiškos padavimo data | 2013-04-29 | |
(97) | Europos patento paraiškos paskelbimo data | 2015-03-11 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2019-06-12 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/IB2013/053377 |
Data | 2013-04-29 |
(87) | Numeris | WO 2013/164754 |
Data | 2013-11-07 |
(30) | Numeris | Data | Šalis |
201261642844 P | 2012-05-04 | US |
(72) |
BINDER, Joseph John, US
CHO, Helen Kim, US
DERMYER, Michael Robert, US
JOOSS, Karin Ute, US
PIERCE, Brian Gregory, US
TAN, Joyce Tsi, US
TSAI, Van To, US
|
(73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
(54) | PROSTATE-ASSOCIATED ANTIGENS AND VACCINE-BASED IMMUNOTHERAPY REGIMENS |
PROSTATE-ASSOCIATED ANTIGENS AND VACCINE-BASED IMMUNOTHERAPY REGIMENS |